Nrf2 activation via Keap1 deletion or sulforaphane treatment reduces Ova-induced sinonasal inflammation

Nyall R. London, Anuj Tharakan, Michelle Mendiola, Mengfei Chen, Alex Dobzanski, Thomas E. Sussan, Michael Zaykaner, Andrew H. Han, Andrew P. Lane, Venkataramana Sidhaye, Shyam Biswal, Murugappan Ramanathan

Research output: Contribution to journalLetterpeer-review

Fingerprint

Dive into the research topics of 'Nrf2 activation via Keap1 deletion or sulforaphane treatment reduces Ova-induced sinonasal inflammation'. Together they form a unique fingerprint.